Alto Neuroscience ANRO
$25.37 −$1.14 (-4.30%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.37 0.00%
Open$25.76
Prev close$26.51
Day range$24.40 – $26.48
Volume522.5K
Market cap$1.02B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$0.00
Operating profit-$27.23M-82.1% YoY
Net profit-$25.12M-77.2% YoY
Diluted EPS-$0.54-3.8% YoY
Free cash flow-$20.76M-109.3% YoY
Operating cash flow-$20.76M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Return on equity-46.6%
Return on assets-40.2%
Return on invested capital-44.5%
Current ratio18.12
Liabilities / assets9.2%
Cash & investments$319.34M
Total debt$16.65M
Net cash (debt)$302.69M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $0.00 | $0.00 | $0.00 | – | – |
| Total Operating Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expense | $27.23M | $29.13M | $27.14M | $66.36M | $17.06M |
| Selling and Admin Expenses | $9.06M | $7.02M | $6.84M | $20.75M | $5.06M |
| -General & Admin Expense | $9.06M | $7.02M | $6.84M | $20.75M | $5.06M |
| Research & Development | $18.16M | $22.11M | $20.29M | $45.62M | $12.00M |
| Operating Profit | -$27.23M | -$29.13M | -$27.14M | -$66.36M | -$17.06M |
| Net Non-Operating Interest Income (Expense) | $2.14M | $1.62M | $1.02M | $4.13M | $986,000.00 |
| Non-Operating Interest Income | $2.60M | $2.11M | $1.56M | $6.60M | $1.56M |
| Non-Operating Interest Expense | $463,000.00 | $491,000.00 | $545,000.00 | $2.47M | $575,000.00 |
| Other Income (Expense) | -$36,000.00 | -$130,000.00 | -$115,000.00 | -$1.01M | -$113,000.00 |
| Special Income (Charges) | $0.00 | $0.00 | $0.00 | -$681,000.00 | $0.00 |
| Other Non-Operating Income (Expenses) | -$36,000.00 | -$130,000.00 | -$115,000.00 | -$327,000.00 | -$113,000.00 |
| Pretax Profit | -$25.12M | -$27.64M | -$26.24M | -$63.24M | -$16.18M |
| Net Profit | -$25.12M | -$27.64M | -$26.24M | -$63.24M | -$16.18M |
| Profit from Continuing Operations | -$25.12M | -$27.64M | -$26.24M | -$63.24M | -$16.18M |
| Net Income to Parent Company | -$25.12M | -$27.64M | -$26.24M | -$63.24M | -$16.18M |
| Net Income to Common Stockholders | -$25.12M | -$27.64M | -$26.24M | -$63.24M | -$16.18M |
| Basic EPS | -$0.54 | -$0.65 | -$0.80 | -$2.19 | -$0.45 |
| Diluted EPS | -$0.54 | -$0.65 | -$0.80 | -$2.19 | -$0.45 |
| -Less:Other Special Charges | – | – | – | $681,000.00 | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $326.51M | $254.07M | $276.26M | $184.69M | $184.69M |
| Total Current Assets | $323.20M | $247.32M | $269.13M | $177.72M | $177.72M |
| Cash and Cash Equivalents & Short-Term Investments | $319.34M | $243.73M | $263.76M | $176.48M | $176.48M |
| -Cash and Cash Equivalents | $319.34M | $243.73M | $263.76M | $176.48M | $176.48M |
| Prepaid Assets | $3.85M | $3.59M | $5.36M | $1.23M | $1.23M |
| Total Non-Current Assets | $3.31M | $6.75M | $7.13M | $6.97M | $6.97M |
| Net PPE | $2.74M | $5.91M | $6.30M | $6.13M | $6.13M |
| -Gross PPE | $4.81M | $7.80M | $8.00M | $7.66M | $7.66M |
| -Accumulated Depreciation | -$2.06M | -$1.89M | -$1.71M | -$1.53M | -$1.53M |
| Other Non-Current Assets | $566,000.00 | $838,000.00 | $838,000.00 | $838,000.00 | $838,000.00 |
| Total Liabilities | $29.98M | $34.82M | $32.89M | $33.55M | $33.55M |
| Total Current Liabilities | $17.84M | $16.65M | $13.12M | $11.33M | $11.33M |
| Payables | $3.47M | $4.02M | $3.37M | $1.88M | $1.88M |
| -Accounts Payable | $3.47M | $4.02M | $3.37M | $1.88M | $1.88M |
| Current Accrued Expenses | $8.48M | $7.50M | $6.31M | $7.71M | $7.71M |
| Short-Term Debt and Capital Lease Obligation | $5.88M | $5.13M | $3.44M | $1.74M | $1.74M |
| -Current Debt | $4.52M | $3.77M | $2.14M | $585,000.00 | $585,000.00 |
| -Current Capital Lease Obligation | $1.37M | $1.36M | $1.30M | $1.15M | $1.15M |
| Total Non-Current Liabilities | $12.14M | $18.17M | $19.78M | $22.22M | $22.22M |
| Long Term Debt and Capital Lease Obligation | $12.14M | $18.17M | $19.78M | $22.22M | $22.22M |
| -Long Term Debt | $11.47M | $14.88M | $16.22M | $18.40M | $18.40M |
| -Long Term Capital Lease Obligation | $673,000.00 | $3.28M | $3.56M | $3.82M | $3.82M |
| Total Equity | $296.53M | $219.25M | $243.37M | $151.14M | $151.14M |
| Stockholders' Equity | $296.53M | $219.25M | $243.37M | $151.14M | $151.14M |
| Capital Stock | $4,000.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| -Common Stock | $4,000.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| Additional Paid-In Capital | $577.14M | $474.74M | $471.22M | $352.75M | $352.75M |
| Retained Earnings | -$280.63M | -$255.51M | -$227.87M | -$201.63M | -$201.63M |
| Gains/Losses Not Affecting Retained Earnings | $19,000.00 | $17,000.00 | $13,000.00 | $22,000.00 | $22,000.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$20.76M | -$19.76M | -$27.09M | -$51.77M | -$11.52M |
| Net cash flow from continuing operations | -$20.76M | -$19.76M | -$27.09M | -$51.77M | -$11.52M |
| Net Income from Continuing Operations | -$25.12M | -$27.64M | -$26.24M | -$63.24M | -$16.18M |
| Gain/Loss from Continuing Operations | $8,000.00 | $0.00 | $9,000.00 | $837,000.00 | $0.00 |
| Depreciation & Depletion & Amortization | $181,000.00 | $184,000.00 | $184,000.00 | $661,000.00 | $157,000.00 |
| Other Non-Cash Items | $849,000.00 | $498,000.00 | $522,000.00 | $1.83M | $463,000.00 |
| Change in Working Capital | -$187,000.00 | $3.64M | -$4.39M | $33,000.00 | $2.10M |
| -Change in Prepaid Assets | -$321,000.00 | $1.78M | -$4.13M | $101,000.00 | $656,000.00 |
| -Change in Payables and Accrued Expense | $134,000.00 | $1.86M | -$263,000.00 | -$68,000.00 | $1.44M |
| Net cash flow from investing | $0.00 | $0.00 | -$556,000.00 | -$24,000.00 | $0.00 |
| Net Cash Flow from Continuing Investing Activities | $0.00 | $0.00 | -$556,000.00 | -$24,000.00 | $0.00 |
| Capital Expenditure | $0.00 | $0.00 | -$556,000.00 | -$24,000.00 | $0.00 |
| Financing Cash Flow | $96.37M | -$273,000.00 | $114.94M | $60.08M | $50.19M |
| Net Cash Flow from Continuing Financing Activities | $96.37M | -$273,000.00 | $114.94M | $60.08M | $50.19M |
| Net Issuance Payments Of Debt | $0.00 | $0.00 | $0.00 | $9.48M | $0.00 |
| Net Common Stock Issuance | $94.60M | -$348,000.00 | $115.13M | $49.83M | $49.83M |
| Proceeds from Stock Option Exercised | $1.77M | $75,000.00 | $6,000.00 | $703,000.00 | $352,000.00 |
| Ending Cash Balance | $319.84M | $244.23M | $264.26M | $176.98M | $176.98M |
| Net Change in Cash | $75.61M | -$20.03M | $87.29M | $8.29M | $38.67M |
| Beginning Cash Balance | $244.23M | $264.26M | $176.98M | $168.73M | $138.32M |
| Effect of Exchange Rate Changes | $2,000.00 | $4,000.00 | -$16,000.00 | -$30,000.00 | -$1,000.00 |
| Free Cash Flow | -$20.76M | -$19.76M | -$27.65M | -$51.79M | -$11.52M |
| Net Other Financing Charges | – | – | -$190,000.00 | $67,000.00 | $0.00 |
No comments yet — be the first to weigh in on ANRO.
Sign in to join the discussion.